APA (7th ed.) Citation

Y, Z., Z, L., J, R., EJ, B., NR, M., DA, D., . . . TU, B. (2025). Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platform. Cell reports. Medicine, 6(7), 102198. https://doi.org/10.1016/j.xcrm.2025.102198

Chicago Style (17th ed.) Citation

Y, Zhang, et al. "Immune Targeting of Triple-negative Breast Cancer Through a Clinically Actionable STING Agonist-CAR T Cell Platform." Cell Reports. Medicine 6, no. 7 (2025): 102198. https://doi.org/10.1016/j.xcrm.2025.102198.

MLA (9th ed.) Citation

Y, Zhang, et al. "Immune Targeting of Triple-negative Breast Cancer Through a Clinically Actionable STING Agonist-CAR T Cell Platform." Cell Reports. Medicine, vol. 6, no. 7, 2025, p. 102198, https://doi.org/10.1016/j.xcrm.2025.102198.